Physician profile
Tamara S Old
NPI 1104906759
$1,707.30
in general payments reported to CMS, 2019-2025
14 companies · $44.92 in 2025
The $44.92 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $960 · 2022: $19.95 · 2023: $327 · 2024: $356 · 2025: $44.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| The Walman Optical Company | $960.00 | 2020 | |
| Alcon Vision LLC | $149.99 | 2024 | Hydrus Microstent |
| Astellas Pharma US INC | $121.02 | 2023 | |
| Horizon Therapeutics Plc | $114.12 | 2023 | Tepezza |
| Apellis Pharmaceuticals, INC. | $100.14 | 2024 | Syfovre |
| Oyster Point Pharma, INC. | $96.34 | 2023-2024 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $35.94 | 2024 | |
| Tarsus Pharmaceuticals, INC. | $24.01 | 2025 | Xdemvy |
| Dompe US, INC. | $20.91 | 2025 | Oxervate |
| Optos, INC. | $19.95 | 2022 | |
| Coopervision INC. | $17.62 | 2023 | Onefit Contact Lens |
| Johnson & Johnson Vision Care, INC. | $16.54 | 2023 | Acuvue |
| Johnson & Johnson Surgical Vision, INC. | $15.74 | 2023 | Lipiflow System Activator (Disposable) |
| Bausch & Lomb Americas INC. | $14.98 | 2024 | Infuse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Old listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.